Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers

Thejus Jayakrishnan; Yasmine Baca; Joanne Xiu; Mehrie Patel; Benjamin A. Weinberg; Emil Lou; Jashodeep Datta; Moh'd Khushman; Pat Gulhati; Sanjay Goel; Tiago Biachi de Castria; Vaia Florou; Kanika G. Nair; Suneel D. Kamath; Alok A. Khorana

Journal Article

Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers

Jayakrishnan T
Baca Y
Xiu J
et al.

JCO Precision Oncology (2024) (8)

DOI: 10.1200/po.24.00138

9Citations

4Readers

Get full text

Abstract

Multiomic analysis shows higher FGFR2 fusions and #immunotherapy marker variations in early-onset biliary cancer

Cite

CITATION STYLE

APA

Jayakrishnan, T., Baca, Y., Xiu, J., Patel, M., Weinberg, B. A., Lou, E., … Khorana, A. A. (2024). Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers. JCO Precision Oncology, (8). https://doi.org/10.1200/po.24.00138

Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers

Abstract

Cite

Register to see more suggestions